MANILA, Philippines – A synthetic opioid used for pain relief has been added to the list of dangerous drugs based on regulations issued by the Dangerous Drugs Board (DBB).
According to Philippine Drug Enforcement Agency (PDEA) Director General Undersecretary Jose Gutierrez, the DDB issued last December 16, 2010 Regulation Number 1, series of 2010 that classified Nalbuphine Hydrochloride as a dangerous drug effective January 28, 2011.
PDEA said Nalbuphine Hydrochloride’s analgesic potency and characteristics are similar to that of Morphine, Demerol, Pethidine or Codeine.
PDEA reminded all importers, manufacturers, wholesalers/distributors/traders and retailers of the drug to register and apply for license with the Compliance Service (CS), the regulatory arm of the agency.
Only practitioners with valid S-2 License can prescribe the said pharmaceutical product through DOH-prescribed "yellow prescription" for a maximum of only 40 milligrams per prescription. Importation, likewise, requires an import permit duly approved by the agency.
The PDEA chief said that based on the foregoing DDB Regulations, PDEA, as the lead anti-drug agency in partnership with the Philippine National Police, National Bureau of Investigation, Bureau of Customs and other instrumentalities in the field of drug law enforcement, will include this substance in their close monitoring and will apprehend offenders of the law.